Three new studies, two in mice and one in humans, have uncovered new genes required for male fertility. The studies may result in a more comprehensive understanding of fertility and provide potential leads in the quest for a non-hormonal male contraceptive.
Lee Smith et al. performed a genetic screen for sterility in male mice and found a point mutation in a gene that encodes a protein with high sequence identity to katanin p60. Katanin p60, together with its partner katanin p80, forms a highly-conserved protein complex that regulates microtubule dynamics; p60 severs microtubules and p80 is thought to regulate the enzymatic activity of the complex.
Smith et al. dubbed the p60-like protein KATNAL1 (katanin p60 subunit A-like 1) and showed that it is expressed in testicular Sertoli cells in both mice and humans. The protein was found to control Sertoli cell microtubule dynamics, which support sperm development. Mice mutant for KATNAL1 released their sperm into the tubules of the testes before they were fully developed, making the mice infertile.
In the second study, Liza O'Donnell performed a similar screen for male mouse sterility and identified a point mutation in katanin p80. Although it is found in Sertoli cells, the protein was highly expressed in spermatocytes and spermatids. The researchers found that the protein has a role in building microtubule structures that control sperm motility, sperm head shape, and exit from meiosis-functions it probably performs with katanin p60. The human condition that describes sperm defects analogous to those of the p80 mutant is called oligoasthenoteratozoospermia.
Targeting katanin p80 and KATNAL1 has the potential to reversibly block sperm formation, but there are several caveats. For instance, katanin p80 and KATNAL1 may have additional functions in the body, since they are both expressed in many different cell types. Whether mutations in these genes contribute to human infertility remains a question.
In the human study, Gülüm Kosova et al. took a non-traditional approach to identify genes involved in human fertility. Most studies to date have looked for such genes by analyzing men who are infertile, but that approach is limited. Much human infertility is unexplained, and very little is known about genes that contribute to natural variations in fertility.
To look for such genes, the researchers examined Hutterites, members of a religious group that forbids contraception and desires large families. The team performed a genome-wide association study of two fertility traits: family size and birth rate. They uncovered 41 genetic regions that influence fertility, including nine loci that affected sperm quality or function. These nine genes encoded for proteins with a range of functions, including the immune response and sperm head formation. The researchers suggest that mutations in these genes may underlie some instances of low fertility and account for some of the unexplained infertility in the population.
These three studies illustrate how research into male fertility at both the molecular and population level is advancing rapidly, providing new avenues in the search for male contraceptives. Geneticists have now sequenced the DNA of an unborn fetus using only blood samples from the mother and saliva from the father.
In humans, fetal cell-free DNA from the syncytiotrophoblast can be found in maternal plasma early in gestation. Thus, blood plasma of a pregnant woman contains cell-free DNA from her own cells as well as from her fetus-which accounts for about 13 percent of the DNA. This finding has recently been exploited as a means of prenatal diagnosis of trisomy and other genetic anomalies.
Jacob Kitzman et al. have carried this technology to a new level by sequencing the fetal DNA from maternal plasma. They determined which sequences were fetal in origin by taking into account the expected ratio of maternal to fetal DNA and the maternal and paternal ''haplotype''-unique genetic variants residing on the same chromosome.
The researchers undertook this analysis in a woman carrying a fetus at 18.5 weeks of gestation and confirmed their results by sequencing the DNA of the baby after it was born.
They were able to predict inherited mutations at most variant sites (2.8 3 10 6 sites) with 98.2-percent accuracy. (The researchers did not attempt to predict 7.5 3 10 5 sites for various reasons, such as a heterozygous genotype in both parents.) The analysis was also able to predict de novo mutations (39 out of 44), but with a high false-positive rate. Similar results were obtained on an 8.2-week-old fetus, although with 95-percent accuracy.
These findings build on previous work that examined singlenucleotide polymorphisms in fetal DNA in blood and placental tissue derived from chorionic villus sampling. The results herald a new day of prenatal screening for genetic disorders. There may be biological advantages to fathering children at an advanced age. A new study shows that the children and grandchildren of older fathers have particularly long telomeres, the DNA caps at the end of chromosomes. Whether these longer telomeres translate into better health or longevity remains unclear, but previous studies have shown an association between short telomeres, cellular senescence, and shorter lifespan.
In most somatic cells, telomeres shorten with age. But in sperm, telomere length increases with a man's age, perhaps because the telomerase enzyme has high activity in the testes. Offspring of older fathers have particularly long telomeres, but until now no one had shown that the effect is detectable across more than one generation.
Dan Eisenberg et al. examined the length of telomeres in the blood of hundreds of individuals and correlated it with the age of their fathers and grandfathers. They report that grandchildren of older paternal grandfathers have particularly long telomeres, with the gain per year of grandfather's life equivalent to the yearly loss of telomere length seen in the middle-aged and elderly women in the study. People with both an older father and an older paternal grandfather had even longer telomeres. Mom's family had much less influence; older maternal grandfathers had grandchildren with elongated telomeres, but the effect was not statistically significant.
The findings have evolutionary implications. If having longer telomeres at birth translates into increased longevity, then the average lifespan of humans may be more plastic that previously believed. On the negative side, there are known risks to fathering children at an older age, given that sperm accumulate mutations with age. Recent studies, for instance, have shown an increased incidence of autism and schizophrenia associated with older fathers. An essential event for embryo implantation is the decidualization of the endometrial stroma in which underlying stromal cells enlarge and undergo other changes in preparation for pregnancy. In rodents, decidualization is prompted by the embryo, which releases the serine protease trypsin. Trypsin release leads the endometrial epithelial cells to produce prostaglandins, which mediate decidualization.
A study in Nature Medicine now fleshes out the unknown molecular events between trypsin release and production of prostaglandins. Ye Chun Ruan and Jing Hui Guo report that trypsin activates a sodium channel in the mother's cells, leading to upregulation of cyclooxygenase 2, a.k.a. Ptgs2, the inducible form of the enzyme required for production of prostaglandins.
ENaC (epithelial sodium channel) is known to be activated by serine proteases in various tissues and is upregulated in the endometrium during the time of implantation. To examine the role of ENaC in implantation, the researchers first turned to cell culture experiments. They found that trypsin activates ENaC in mouse endometrial epithelial cells, leading to an influx of calcium, upregulation of Ptgs2 via a calcium-activated transcription factor (CREB), and release of prostaglandins-all leading to the morphological changes in stromal cells that are characteristic of decidualization.
The researchers verified their findings in mice, showing for instance that knocking out ENaC activity in mice with an inhibitor or with siRNA affects embryo implantation.
In humans, decidualization occurs spontaneously during each menstrual cycle but may similarly involve ENaC. The researchers looked at the levels of ENaC in women undergoing in vitro fertilization (IVF) and found that ENaC expression is reduced in women with implantation failure compared with women with successful pregnancies.
The researchers speculate that ovarian stimulation during IVF may affect ENaC expression, which is known to respond to ovarian hormones. Future studies will help establish whether changes in ENaC may contribute to the spontaneous miscarriage and implantation failure often seen during IVF.
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